Lifecore Biomedical Files 8-K with Office and Former Name Details
Ticker: LFCR · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1005286
| Field | Detail |
|---|---|
| Company | Lifecore Biomedical, Inc. \De\ (LFCR) |
| Form Type | 8-K |
| Filed Date | Jan 7, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-information, filing-update
TL;DR
Lifecore Biomedical (formerly Landec Corp) updated its 8-K with HQ address in Chaska, MN.
AI Summary
On January 7, 2025, Lifecore Biomedical, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 3515 Lyman Boulevard, Chaska, Minnesota, 55318, with a business phone number of 952-368-4300. The company was formerly known as Landec Corp. and was incorporated in Delaware.
Why It Matters
This filing provides updated corporate information, including the company's current address and former name, which is important for investors and stakeholders to accurately identify and track the company.
Risk Assessment
Risk Level: low — This is a routine administrative filing providing corporate information and does not indicate any significant operational or financial changes.
Key Players & Entities
- Lifecore Biomedical, Inc. (company) — Registrant
- 3515 Lyman Boulevard, Chaska, Minnesota, 55318 (location) — Principal executive offices
- 952-368-4300 (phone_number) — Business phone number
- Landec Corp (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is January 7, 2025.
What is the current address of Lifecore Biomedical, Inc.'s principal executive offices?
The principal executive offices are located at 3515 Lyman Boulevard, Chaska, Minnesota, 55318.
What was Lifecore Biomedical, Inc.'s former name?
The company was formerly known as Landec Corp.
In which state was Lifecore Biomedical, Inc. incorporated?
Lifecore Biomedical, Inc. was incorporated in Delaware.
What is the telephone number for Lifecore Biomedical, Inc.?
The registrant's telephone number, including area code, is (952) 368-4300.
Filing Stats: 509 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-07 09:07:21
Filing Documents
- lndc-20250107.htm (8-K) — 26KB
- a2025-01x07form8xkex991.htm (EX-99.1) — 12KB
- image_0a.jpg (GRAPHIC) — 50KB
- 0001005286-25-000014.txt ( ) — 232KB
- lndc-20250107.xsd (EX-101.SCH) — 2KB
- lndc-20250107_lab.xml (EX-101.LAB) — 21KB
- lndc-20250107_pre.xml (EX-101.PRE) — 12KB
- lndc-20250107_htm.xml (XML) — 3KB
01 Regulation FD
Item 7.01 Regulation FD. On January 7, 2025, Lifecore Biomedical, Inc. ("the "Company") issued a press release announcing the sale of the Company's 10-head isolator filler. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. The following exhibits are furnished as part of this report: Exhibit No. Description 99.1 Press Release issued January 7 , 2025 by Lifecore Biomedical, Inc. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 7, 2025 LIFECORE BIOMEDICAL, INC. By: /s/ Ryan D. Lake Ryan D. Lake Chief Financial Officer